)
Visual
earnings real time
Oxford Biomedica (OXB) investor relations material
Oxford Biomedica Jefferies London Healthcare Conference 2025 summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Jefferies London Healthcare Conference 2025 summary18 Nov, 2025
Strategic positioning and market opportunity
Focused exclusively on Cell and Gene Therapy as a pure play, innovation-led CDMO with a unique position in viral vector manufacturing.
State-of-the-art facilities in the U.S., U.K., and France provide scalable capacity and proximity to major client clusters.
U.S. expansion prioritized due to its large market, client proximity, and favorable geopolitical and tax conditions.
Acquisition of an FDA-approved Durham facility accelerates U.S. growth and enhances end-to-end service capabilities.
Balanced global footprint offers flexibility and resilience in regulatory and supply chain management.
Commercial performance and portfolio development
Signed orders rose from GBP 56 million to over GBP 149 million in H1 2025, a 160% increase.
80% of contracts are from existing clients, with new business mainly in AAV; business is becoming more international.
Portfolio maturing with growth in both early- and late-stage clinical programs, supporting future commercial transitions.
Five late-stage programs are expected to transition to commercial within the next years.
Current capacity is sufficient for anticipated late-stage program commercialization, with room for expansion.
Innovation and operational excellence
Innovation is client-centric, focusing on vector engineering, process improvements, AI-driven analytics, and automated batch release.
AI and machine learning are increasingly used to enhance yield, quality, and speed in production.
Operational progress includes manufacturing optimization and regional team alignment.
Revenue increased over 40% in H1 2025, with EBITDA loss narrowing to GBP 8.3 million.
Financial flexibility strengthened by a $125 million loan and GBP 60 million equity raise.
How does US localization mitigate geopolitical risks?
What underpins confidence in 30% EBITDA margin?
What drives high client retention and portfolio maturation?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Oxford Biomedica earnings date
CMD 20255 Jan, 2026
Next Oxford Biomedica earnings date
CMD 20255 Jan, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
)
Frequently asked questions
Oxford Biomedica plc, a biopharmaceutical company, engages in the research, development and bioprocessing of cell and gene therapy products in Europe and internationally. The company's products are designed to treat diseases by replacing or enhancing a patient's defective genes with normal or healthy copies in order to restore or correct its function. Oxford Biomedica plc was founded in 1995 and is headquartered in Oxford, the United Kingdom.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage